Adoption Of Breast Cancer Diagnostics At Hospital-Associated Labs Is Expected To Account For Nearly 50% Revenue Share

24 Aug 2022
www.biospace.com
Cell TherapyCollaborate
North America Is Expected To Witness 45% Of Breast Cancer Diagnostics Market Share Due To Well-Established Diagnostic Infrastructure And Technological Advancements Fact.MR – A Market Research and Competitive Intelligence Provider: The global breast cancer diagnostics market is expected to witness a market value of US $ 4 Billion in 2022 and is expected to witness a CAGR of 7% during forecast period 2022-2032. Rise in prevalence of breast cancer is positively influencing the demand for breast cancer diagnostics. The number of breast cancer cases is rising rapidly and early detection of breast cancer tumors is one of the major challenges in diagnosis and treatment, as in most cases, they are detected after they have grown to an advanced stage. In addition to this, biopsy for breast cancer diagnostics, breast cancer diagnostic PCR tests and adoption of microarray in breast cancer diagnostics are the growth drivers for the market. Also, well-established diagnostic infrastructure, technological advancements, increasing healthcare expenditure, and rising awareness about breast cancer are some of the factors that are fuelling the growth of the market. For more insights into the Market, Request Brochure of this Report Surge in hospitalization of patients, increasing prevalence of breast cancer, and rise in demand for biopsy procedure in breast cancer diagnostics are the factors driving the growth of the market. Besides this, rising prevalence of malignant genes among women has been witnessed. Moreover, fear of passing on the same gene across families is pushing them to opt for breast care diagnostics. Key Takeaways: North America is anticipated to dominate for more than 45% of global breast cancer diagnostics market share in the forecast period 2022-2032. Moreover, demand for Demand for breast cancer diagnostics in the U.S. is anticipated to increase at a high CAGR owing to rising cases across the nation. Asia Pacific is expected to account for more than 40% market share for breast cancer diagnostics market growth through 2032. Moreover, rise in development of cost-effective diagnostic solutions in countries such as India is expected to contribute to the market share. Adoption of breast cancer diagnostics at hospital-associated laboratories is high and is expected to witness around 50% revenue share of the global market in 2032. Growth Drivers: Well-established diagnostic infrastructure, increasing healthcare expenditure, technological advancements, and rising awareness about breast cancer are some of the driving factors that boost the growth of the market. Rising instances of cancer in various countries across the globe is driving demand for early breast cancer diagnostics. For instance, breast cancer accounts for around 14% of all cancers diagnosed in Indian women. Rising hospitalization of patients and rise in demand for biopsy procedure in breast cancer diagnostics are some of the factors driving the growth of the market. Significant research has been conducted on innovative and early diagnostics solutions for breast cancer and this trend is expected to be prevalent through the decade. Governments across the globe are taking various initiatives to raise awareness about breast cancer. Various initiatives taken by government and cancer organizations are boosting the market growth. For Comprehensive Insights Ask An Analyst Here Competitive Landscape: Prime providers of breast cancer diagnostics are focusing on solutions that offer early detection of breast cancer. Key market players are also investing in the research & development to develop that are fast, cost-efficient, and accurate. In September 2021, Elizabeth Hurley, launched a cancer support center in London, ahead of the cancer awareness month. The support center was named Future Dreams House. In October 2021, WellSpan Health collaborated with Capital Blue to launch a mobile mammography motor coach, which increases screening for breast cancer across five countries. Key Companies Profiled by Fact.MR Bio-Rad Laboratories Inc. Illumina Inc. Biocept Inc. Epigenomics AG AstraZeneca plc Myriad Genetics Inc. Quest Diagnostics Incorporated. More Valuable Insights on Breast Care Diagnostics Market By Test Type CA Tests for Breast Cancer BRCA Test for Breast Cancer ER & PR Test for Breast Cancer CEA Test for Breast Cancer KRAS Mutation Test for Breast Cancer HER 2 Test for Breast Cancer PSA Test for Breast Cancer EGFR Mutation Test for Breast Cancer Immunohistochemistry for Breast Cancer Others By End User Hospital Associated Labs Independent Diagnostic Laboratories Cancer ResearchCancer Research Institutes Others Get Customization on this Report for Specific Research Solutions Explore Fact.MR’s Coverage on the Healthcare Domain Lithotripsy Devices Market - Lithotripsy is a popular procedure for treating kidney stones, owing to its relative safety, low cost, shorter recovery time, and favourable patient results. As a result, all of these variables are responsible for the market's expansion. From 2021 to 2031, sales are expected to grow at around 5% CAGR. Animal Genetics Market - Livestock farmers are achieving high milk- and meat-production by leveraging animal genetic technology. Through strategic breeding, livestock farmers are able to achieve relatively higher gains, which is projected to broaden the end-user base of the animal genetics market. Anticoagulant Reversal Drugs Market - Favourable regulatory scenario, especially in developed economies of North America and Europe, has inadvertently created a highly conducive environment for the growth of the anticoagulant reversal drugs market. Anticancer Drugs Market - The National Breast Cancer Foundation, Inc.Breast Cancer Foundation, Inc. runs an annual campaign by observing October as breast cancer awareness month, to spread information regarding the disease and encourage women to undergo screening tests. Apheresis Market - The introduction of new therapy lines such as stem cell therapy, immunoglobulin therapy, and radiotherapy for control and prevention of chronic diseases is inadvertently bolstering the adoption of apheresis procedures, in turn boosting the growth of the global apheresis market. Dental 3D Printing Market - Dental technicians and clinicians are progressively turning receptive to digital dentistry, which is opening lucrative avenues for manufacturers of 3D printers to progress with a customised, rather than standardised approach in the dental 3D printing market. About Fact.MR Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000's trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis. Contact: Mahendra Singh US Sales Office 11140 Rockville Pike Suite 400 Rockville, MD 20852 United States Tel: +1 (628) 251-1583 E: sales@factmr.com Follow Us: LinkedIn | Twitter
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.